asa guidelines for glp-1 drugs Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement A narrative review of glucagon-like

From 4 mg, increase to 6 or 8 mg

BSW Health

The risk of MACE was also significantly reduced in consecutive studies (Harmony Outcomes [18], REWIND [19], AMPLITUDE-O [20])

When using GLP-1 medications, certain foods and eating habits should be minimized or avoided because they may reduce treatment benefits, increase side effects, contribute to poor nutrition, interfere with blood sugar control, or affect healthy weight reduction

If symptoms are genuinely anxiety-related rather than medication side effects, they typically persist beyond the immediate post-injection period and occur independently of blood glucose levels or gastrointestinal symptoms

doi:10.1016/j.cmet.2013.04.008 2